Emergency Department-initiated Interventions for Patients With Opioid Use Disorder: A Systematic Review.
Journal
Academic emergency medicine : official journal of the Society for Academic Emergency Medicine
ISSN: 1553-2712
Titre abrégé: Acad Emerg Med
Pays: United States
ID NLM: 9418450
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
17
05
2020
revised:
10
06
2020
accepted:
11
06
2020
pubmed:
20
6
2020
medline:
16
2
2021
entrez:
20
6
2020
Statut:
ppublish
Résumé
The opioid crisis has risen dramatically in North America in the new millennium, due to both illegal and prescription opioid use. While emergency departments (EDs) represent a potentially strategic setting for interventions to reduce harm from opioid use disorder (OUD), the absence of a recent synthesis of literature limits implementation and scalability. To fill this gap, we conducted a systematic review of the literature on interventions targeting OUDs initiated in EDs. Using an explicit search strategy (PROSPERO), the MEDLINE, CINAHL Complete, EMBASE, and EBM reviews databases were searched from 1980 to October 4, 2019. The gray literature was explored using Google Scholar. Study characteristics were abstracted independently. The methodologic quality and risk of bias were assessed. Twelve of 2,270 studies met the inclusion criteria (two of high quality). In addition to the heterogeneity of the outcome measures used (retention in treatment, opioid consumption, and overdose), brief intervention and buprenorphine initiation (six of 12 studies) were the most documented with mixed effects for the former and positive short-term and confined to single ED sites effects for the latter. Emergency departments can be an appropriate setting for initiating opioid agonist treatment, but to be sustained, it likely needs to be coupled with community-based follow-up and support to ensure longer-term retention. The scarcity of high-quality evidence on OUD interventions initiated in emergency settings highlights the need for future research.
Substances chimiques
Analgesics, Opioid
0
Buprenorphine
40D3SCR4GZ
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1173-1182Informations de copyright
© 2020 by the Society for Academic Emergency Medicine.
Références
Fox L, Nelson LS. Emergency department initiation of buprenorphine for opioid use disorder: current status, and future potential. CNS Drugs 2019;33:1147-54.
MacDougall L, Smolina K, Otterstatter M, et al. Development and characteristics of the Provincial Overdose Cohort in British Columbia, Canada. PLoS One 2019;14:1-17.
Gomes T, Tadrous M, Mamdani MM, et al. The burden of opioid-related mortality in the United States. JAMA Network Open 2018;1:1-17.
The Daily: Changes in Life Expectancy by Selected Causes of Death, 2017. 2017. Available at: https://www150.statcan.gc.ca/n1/daily-quotidien/190530/dq190530d-eng.htm. Accessed Feb 24, 2020
Special Advisory Committee on the Epidemic of Opioid Overdoses. Opioid-related Harms in Canada. Ottawa: Public Health Agency of Canada, 2020. Available at: https://health-infobase.canada.ca/substance-related-harms/opioids. Accessed Jul 2, 2020.
Johns SE, Bowman M, Moeller FG. Utilizing buprenorphine in the emergency department after overdose. Trends Pharmacol Sci 2018;39:998-1000.
O'Connor S, Grywacheski V, Krista L. At-a-glance - hospitalizations and emergency department visits due to opioid poisoning in Canada. Health Promot Chronic Dis Prev Can 2018;38:244-7.
D'Onofrio G, McCormack RP, Hawk K. Emergency departments-a 24/7/365 option for combating the opioid crisis. N Engl J Med 2018;379:2487.
Houry DE, Haegerich TM, Vivolo-Kantor A. Opportunities for prevention and intervention of opioid overdose in the emergency department. Ann Emerg Med 2018;71:688-90.
Weiner SG, Baker O, Bernson D, Schuur JD. One-year mortality of opioid overdose victims who received naloxone by emergency medical services. Ann Emerg Med 2017;70:S158.
Alberta Opioid Response Surveillance Report Q3 2019. 2019. Available at: https://open.alberta.ca/dataset/f4b74c38-88cb-41ed-aa6f-32db93c7c391/resource/c9e430f9-0951-436a-9b36-f372ee476498/download/health-alberta-opioid-response-surveillance-report-2019-q3.pdf. Accessed July 2, 2020.
Strategies for Addressing the Opioid Crisis in the United States and Canada: Cross-Border Knowledge Sharing. Ottawa: Canadian Centre on Substance Use and Addiction, 2019.
Haegerich TM, Jones CM, Cote PO, et al. Evidence for state, community and systems-level prevention strategies to address the opioid crisis. Drug Alcohol Depend 2019;204:1-13.
Love J, Perrone J, Nelson L. Should buprenorphine be administered to patients with opioid withdrawal in the emergency department? Ann Emerg Med 2018;72:26-8.
Murphy Y, Goldner EM, Fischer B. Prescription opioid use, harms and interventions in Canada: a review update of new developments and findings since 2010. Pain Physician 2015;18:605-14.
Shaw LV, Moe J, Purssell R, et al. Naloxone interventions in opioid overdoses: a systematic review protocol. Syst Rev 2019;8:138.
Moher D,Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151:264-9.
Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 (updated July 2019). Cochrane, 2019. Available at: www.training.cochrane.org/handbook. Accessed July 2, 2020.
Sterne JAC, Hernán MA, McAleenan A, Reeves BC, Higgins JPT. Chapter 25: Assessing risk of bias in a non-randomized study. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available at: www.training.cochrane.org/handbook. Accessed July 2, 2020.
Merchant RC, Baird JR, Liu T. Short-term efficacy of a brief intervention to reduce drug misuse and increase drug treatment utilization among adult emergency department patients. Acad Emerg Med 2015;22:1172-80.
D'Onofrio G, O'Connor PG, Pantalon MV, et al. Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial. JAMA 2015;313:1636-44.
Bogenschutz MP, Donovan DM, Mandler RN, et al. Brief intervention for drug users presenting in emergency departments (NIDA CTN Protocol 0047: SMART-ED). JAMA Intern Med 2014;174:1736.
Banta-Green CJ, Coffin PO, Merrill JO, et al. Impacts of an opioid overdose prevention intervention delivered subsequent to acute care. Injury Prev 2019;25:191-8.
Bohnert AS, Bonar EE, Cunningham R, et al. A pilot randomized clinical trial of an intervention to reduce overdose risk behaviors among emergency department patients at risk for prescription opioid overdose. Drug Alcohol Depend 2016;163:40-7.
Srivastava A, Kahan M, Njoroge I, et al. Buprenorphine in the emergency department: randomized clinical controlled trial of clonidine versus buprenorphine for the treatment of opioid withdrawal. Can Fam Physician 2019;65:e214-20.
Barnett PG, Masson CL, Sorensen JL, et al. Linking opioid-dependent hospital patients to drug treatment: health care use and costs 6 months after randomization. Addiction 2006;101:1797-804.
Whiteside LK, Darnell D, Jackson K, et al. Collaborative care from the emergency department for injured patients with prescription drug misuse: an open feasibility study. J Subst Abuse Treat 2017;82:12-21.
Suffoletto B, Yanta J, Kurtz R, et al. Acceptability of an opioid relapse prevention text-message intervention for emergency department patients. J Addict Med 2017;11:475-82.
Kestler A, Buxton J, Meckling G, et al. Factors associated with participation in an emergency department-based take-home naloxone program for at-risk opioid users. Ann Emerg Med 2017;69:340-6.
Hu T, Snider-Adler M, Nijmeh L, et al. Buprenorphine/naloxone induction in a Canadian emergency department with rapid access to community-based addictions providers. Can J Emerg Med 2019;21:492-8.
Berg M, Idrees U, Ding R, et al. Evaluation of the use of buprenorphine for opioid withdrawal in an emergency department. Drug Alcohol Depend 2007;86:239-44.
D'Onofrio G, Edelman EJ, Hawk KF, et al. Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH). Implement Sci 2019;14:48.
D'Onofrio G, Chawarski MC, O'Connor PG, et al. Emergency department-initiated buprenorphine for opioid dependence with continuation in primary care: outcomes during and after intervention. J Gen Intern Med 2017;32:660-6.
Hawk KF, D'Onofrio G, Chawarski MC, et al. Barriers and facilitators to clinician readiness to provide emergency department-initiated buprenorphine. JAMA Netw Open 2020;3:e204561.